Category: Oncology/Hematology
North America Oncology/Hematology
-
Global Medication Adherence Market- By Type (Software Centric and Hardware Centric); By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others); By Region (North America, Europe, The Asia Pacific, Latin America, The Middle East and Africa); Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... and Africa); Trend Analysis, Competitive Market Share & Forecast, 2018-2028 Global Medication Adherence Market to Surpass USD 5.5 Billion Mark by 2028 The growth of the Medication Adherence market can be attributed to the rising ... Read More
-
Immunotherapy Drugs Market, By Product (Monoclonal Antibodies, Immuno Modulators, Car T-Cell Therapy, Others), By Applications (Cancer, Autoimmune & Inflammatory Diseases, Others), and By Geography (Europe, APAC, North America, Latin America, And Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Immunotherapy is a cancer treatment that enhances the immune system's ability to fight cancer. Immunotherapy is preferable than the old technique as it helps treat a ... Read More
-
Oncology Drugs Market, by Drug Type (Cytotoxic Drugs (Alkylating Agents, Antimetabolites, and Others), Targeted Drugs (Monoclonal Antibodies, Tyrosine Kinase Inhibitors, and Others), and Hormonal Drugs (Ovarian Function Blockers, Estrogen Production Blockers, and Estrogen’s Effect Blockers (Selective Estrogen Receptor Modulators (SERMs) and Others)), by Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Bladder Cancer, and Others), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... (Selective Estrogen Receptor Modulators (SERMs) and Others)), by Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Bladder Cancer, and Others), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and ... Read More
-
United States Liquid Biopsy Market, By Product & Services (Assay Kits, Instruments, Services), By Circulating Biomarker (Circulating Tumor Cells, Circulating Tumor DNA (ctDNA), Cell-free DNA (cfDNA), Others), By Technology (Multi-gene Parallel Analysis using NGS v/s Single-gene Analysis using PCR Microarrays), By Application (Cancer v/s Non-Cancer), By End User (Hospitals & Clinics, Reference Laboratories, Others), By Region, Competition Forecast & Opportunities, 2027
... Single-gene Analysis using PCR Microarrays), By Application (Cancer v/s Non-Cancer), By End User (Hospitals & Clinics, Reference Laboratories, Others), By Region, Competition Forecast & Opportunities, 2027 The United States liquid biopsy market is projected to ... Read More
-
Colorectal Cancer Screening Market, By Screening Tests (Stool-based Tests, Colonoscopy, CT Colonography (Virtual Colonoscopy), Flexible Sigmoidoscopy, and Other Screening Tests), By End User (Hospitals Independent Diagnostic Labs and Other End Users), and By Geography (North America, South America, Europe, Asia-Pacific, and Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... America, South America, Europe, Asia-Pacific, and Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Colorectal cancer is a type of cancer that begins in the large intestine (colon). The ... Read More
-
Global Liquid Biopsy Market, By Sampling Type (Blood Sampling, Urine Sampling, Saliva Sampling, and Other Tissue Fluids Sampling), By Product and Service (Assay Kits, Instruments, and Services), By Circulating Biomarker (Circulating Tumor Cells, Circulating Tumor DNA), By Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), By Application (Cancer Applications, Non-Cancer Applications), By End User (Reference Laboratories, Hospitals, Physician Laboratories, Academic Researchers, and Others), By Region (North America, Europe, The Asia Pacific, Latin America, and The Middle East and Africa)Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... DNA), By Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), By Application (Cancer Applications, Non-Cancer Applications), By End User (Reference Laboratories, Hospitals, Physician Laboratories, Academic Researchers, and Others), By Region (North America, ... Read More
-
Cancer Biomarkers Market, by Biomarker Type (Protein Biomarkers, Genetic Biomarkers, and Other Cancer Biomarkers), by Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Kidney Cancer, Liver Cancer, and Other Cancers), by End User (Hospitals, Academic and Cancer Research Institutes, Ambulatory Surgical Centers, and Cancer Diagnostic Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... and Cancer Research Institutes, Ambulatory Surgical Centers, and Cancer Diagnostic Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 ... Read More
-
U.S. Digital Therapeutics Market - Industry Outlook and Forecast 2022-2027
... to the growth of the U.S. digital therapeutics market: Rise in Chronic Diseases and Need for Controlling Healthcare Costs Increase in Adoption of Healthcare Applications & Smart Wearables Rising Importance of A.I. in Digital Therapeutics ... Read More
-
2022 Mexico Immunodiagnostic Analyzers and Reagents - Supplier Shares and Competitive Analysis, Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Instrumentation Pipeline, Emerging Opportunities for Suppliers This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during ... Read More
-
2022 US Immunodiagnostic Analyzers and Reagents - Supplier Shares and Competitive Analysis, Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch’s new report is a study of the major business opportunities emerging in the U.S. immunodiagnostic market during the next five years. The report explores future trends in the ... Read More
-
2022 Global Immunodiagnostic Analyzers and Reagents - USA, Europe, Japan - Supplier Shares and Competitive Analysis, Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Tests - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a seven-country strategic analysis of major business opportunities emerging in the immunodiagnostic market during the next five years. The report explores ... Read More
-
2022-2026 US Clinical Chemistry Market Database - Supplier Shares, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
... available from any other published source . The report is available by section, and can be customized to specific information needs and budget. This database from LeadingMarketResearch.com provides the 2021 supplier shares, the 2021-2026 volume ... Read More
-
2022-2026 Global Clinical Chemistry Market Database for the US, Europe, Japan - Supplier Shares, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
... provides information and analysis not available from any other published source . The report is available by section, and can be customized to specific information needs and budget. This database from LeadingMarketResearch.com provides the 2021 ... Read More
-
2022-2026 Canada Cancer Diagnostics Market Database - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and ... Read More
-
2022-2026 Global Cancer Diagnostics Market Database for the USA, Europe, Japan - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... information and analysis not available from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing ... Read More
-
2022-2026 US Cancer Diagnostics Market Database - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and ... Read More
-
2022-2026 Mexico Cancer Diagnostics Market Database - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and ... Read More
-
2022-2026 North America Cancer Diagnostics Market Database for the USA, Canada, Mexico - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... provides information and analysis not available from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies ... Read More
-
U.S. Solid Tumor Testing Market - A Country Analysis: Focus on Technology, Cancer Type, Type of Biomarker, By Application, by End User, and Region - Analysis and Forecast, 2022-2032
... Overview The U.S. solid tumor testing market was estimated to be at $9,498.8 million in 2021, which is expected to grow with a CAGR of 6.19% during the forecast period 2022-2032 and reach $18,287.6 million ... Read More
-
Bioanalytical Testing Services Market by Type, Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User and Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2027
... for the detailed examination of biological and biotechnology products. Bioanalysis enables the quantitative measurement of drugs and their metabolites, biological molecules in unnatural locations or concentrations, DNA, and large molecules. The global bioanalytical testing services ... Read More
-
North America Antibody Drug Conjugates Market Size, Share & Industry Trends Analysis Report By Application (Breast Cancer, Blood Cancer, Urothelial Cancer & Bladder Cancer, and Others), By Technology, By Country and Growth Forecast, 2022 – 2028
... 2028 The North America Antibody Drug Conjugates Market would witness market growth of 13.7% CAGR during the forecast period (2022-2028). ADCs are anticancer medications that are one of the quickest treatments for cancer patients, with ... Read More
-
Herceptin Biosimilar Market, by Indication (Breast Cancer, Gastric Cancer, and Others), by Distribution Channel (Hospital, Oncology Centers, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Sh
... Share, Outlook, and Opportunity Analysis, 2022 - 2028 Trastuzumab, sold under the brand Herceptin, is a monoclonal antibody used for the treatment of breast cancer and gastric cancer. Herceptin is mainly used to treat patients ... Read More
-
Cervical Cancer Diagnostic Tests Market, By Test Type (Pap Smear Test, Colposcopy Test, ECC Test, and HPV Test), By Age Group (Age 20 – 40 and Age Above 40), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - S
... America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Cervical cancer occurs in the cells of the cervix. Pap smear, colposcopy, and ECC procedures are performed ... Read More
-
DNA/Gene Microarray Market, By Type (oDNA, cDNA), By Application (Genomics, Proteomics, Agricultural biology, Environment, Drug R&D, Gene expression and SNP analysis, Cancer/oncology, Others), and By Region (North America, Latin America, Europe, Asia Paci
... & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 DNA Chips, Biochips or DNA microarrays consists of a microscope slide made materials such as glass, silicon chips, and nylon membrane, which is ... Read More
-
Medical Tourism Market, by Treatment Type (Cardiovascular, Orthopedic, Neurological, Cancer, Fertility and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysi
... - 2028 Medical tourism refers to people traveling abroad to obtain medical treatment. Factors such as high cost of healthcare and long waiting time for certain procedures have increased the popularity of medical tourism. Domestic ... Read More
Research Assistance
